Fulgent Genetics Inc (FLGT)
Working capital turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 283,470 | 277,761 | 290,705 | 287,530 | 289,213 | 286,412 | 307,380 | 364,868 | 618,968 | 802,935 | 925,148 | 953,423 | 992,584 | 1,035,891 | 909,739 | 773,388 | 421,712 | 135,121 | 43,752 | 34,911 |
| Total current assets | US$ in thousands | 353,571 | 326,539 | 399,104 | 386,509 | 507,845 | 549,855 | 528,289 | 914,867 | 905,632 | 1,022,160 | 675,185 | 1,238,560 | 1,074,460 | 622,836 | 925,615 | 659,140 | 615,726 | 194,650 | 16,294 | 76,995 |
| Total current liabilities | US$ in thousands | 72,899 | 73,990 | 75,751 | 75,949 | 73,018 | 61,421 | 64,819 | 107,848 | 116,178 | 124,385 | 127,527 | 152,630 | 112,840 | 147,158 | 129,130 | 196,530 | 131,074 | 60,356 | 8,872 | 7,953 |
| Working capital turnover | 1.01 | 1.10 | 0.90 | 0.93 | 0.67 | 0.59 | 0.66 | 0.45 | 0.78 | 0.89 | 1.69 | 0.88 | 1.03 | 2.18 | 1.14 | 1.67 | 0.87 | 1.01 | 5.89 | 0.51 |
December 31, 2024 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $283,470K ÷ ($353,571K – $72,899K)
= 1.01
Fulgent Genetics Inc's working capital turnover has exhibited fluctuating trends over the past few years, as reflected in the provided data. The working capital turnover ratio is a measure of how efficiently a company is utilizing its working capital to generate sales revenue.
Based on the data provided:
- The working capital turnover ratio for Fulgent Genetics Inc ranged from a low of 0.45 on March 31, 2023, to a high of 5.89 on June 30, 2020.
- The company's working capital turnover ratio has generally been below 2, indicating that Fulgent Genetics Inc may not be efficiently utilizing its working capital resources to generate sales.
- Notable peaks in the working capital turnover ratio occurred on June 30, 2020, and September 30, 2021, suggesting periods of improved efficiency in working capital management.
- However, there were also periods where the ratio dropped significantly, such as on March 31, 2020, and March 31, 2024, potentially indicating challenges in efficiently converting working capital into sales revenue during those periods.
- The overall trend in the working capital turnover ratio for Fulgent Genetics Inc appears to be somewhat volatile, with variations from period to period.
In conclusion, the working capital turnover ratio for Fulgent Genetics Inc indicates varying levels of efficiency in utilizing working capital to support sales over the specified time frame, suggesting potential fluctuations in the company's working capital management practices.
Peer comparison
Dec 31, 2024